Dr. Reddy's Laboratories
RDY
#1745
Rank
S$15.71 B
Marketcap
S$18.72
Share price
0.54%
Change (1 day)
4.53%
Change (1 year)

Earnings for Dr. Reddy's Laboratories (RDY)

Earnings in 2025 (TTM): S$1.13 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's current earnings are S$3.95 Billion. a decrease over its 2024 earnings that were of S$1.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dr. Reddy's Laboratories from 2002 to 2025

Annual earnings

Year Earnings Change
2025 S$1.10 B-2.73%
2024 S$1.13 B7.01%
2023 S$1.06 B17.62%
2022 S$0.90 B43.27%
2021 S$0.63 B31.44%
2020 S$0.47 B54.54%
2019 S$0.31 B-14.21%
2018 S$0.36 B26.15%
2017 S$0.28 B4.69%
2016 S$0.27 B-55.7%
2015 S$0.61 B1.83%
2014 S$0.60 B-3.78%
2013 S$0.63 B54.07%
2012 S$0.40 B-16.23%
2011 S$0.48 B56.66%
2010 S$0.31 B-235.36%
2009 -S$0.24 Billion-198.53%
2008 S$0.23 B30.77%
2007 S$0.17 B-14.61%
2006 S$0.20 B703.63%
2005 S$26.08 M649.45%
2004 S$3.48 M-95.68%
2003 S$80.5 M-14.86%
2002 S$94.55 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
S$20.71 B 1,772.31%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$15.01 B 1,257.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$11.52 B 941.98%๐Ÿ‡ซ๐Ÿ‡ท France
GSK plc
GSK
S$11.80 B 967.48%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
S$2.72 B 146.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel